Clinical trial
Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic…
NCT00347698 · Asociación para Evitar la Ceguera en México, Other · Withdrawn
Key facts
| NCT number | NCT00347698 |
|---|---|
| Title | Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy |
| Official title | Intravitreal Bevacizumab vs Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A One-year Prospective, Contralateral Eye Study |
| Lead sponsor | Asociación para Evitar la Ceguera en México, Other |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy |
| Intervention type | Drug, Procedure |
| Interventions | intravitreal injection of bevacizumab, panretinal photocoagulation |
| Enrollment | 0 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | May 30, 2024 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: